New initiative aims to provide early-stage biotech and academic partners with greater access to OmniAb’s antibody discovery technologies, supporting innovation and therapeutic development. ...
Final approval clears the way for Zydus to market Glatiramer Acetate, expanding access to a key treatment for multiple sclerosis patients in the U.S. ...
New addition boosts diagnostic accuracy in prostate cancer care, strengthening Covera’s imaging quality program across U.S. healthcare networks...
Award Highlights Glytec’s Leadership in Advancing Safe, Effective Insulin Management Through Innovative Software Solutions...
Innovative treatments now available to address fat loss, skin tightening, and incontinence without surgery...
Innovative Laser Therapy Offers Non-Invasive Treatment Alternative for Millions Living with Arthritis in the U.S....
New Liquid Biopsy Technology Offers Hope in Diagnosing One of the Deadliest Cancers at an Early Stage...
Final patient visit marks major milestone in FDA IDE study, advancing treatment options for patients not eligible for knee replacement....
Breakthrough intravascular lithotripsy device to begin first-in-human trials for treatment of calcified coronary artery disease...
New Fibrosis Biomarker Enhances Diagnostic Capabilities for Chronic Liver Disease Across Global Labs...
![[L-R]: Ms. Vivien Tan, XP Business Manager, Siemens Healthineers ASEAN; Prof. Dr. dr. Lina Choridah, Sp.Rad (K), Chairwoman Indonesian Woman Imaging Society; Hendya Perbangkara, Head of Diagnostic Imaging, Siemens Healthineers Indonesia](/uploads/articles/l_r__ms_vivien_tan_xp_business_manager_siemens_healthineers_asean-24188.jpg)
